[Cytogenetic and therapeutic results of a protocol including splenectomy and intensive polychemotherapy in Ph'-positive chronic myeloid leukemia].
Cervantes
F
F
Rozman
C
C
Ballesta
F
F
Milá
M
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002066:Busulfan / Q000627:therapeutic use; D002999:Clone Cells / Q000648:ultrastructure; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000235:genetics / Q000601:surgery; D010677:Philadelphia Chromosome; D011241:Prednisone / Q000008:administration & dosage; D013156:Splenectomy; D013866:Thioguanine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D003561:Cytarabine; D014750:Vincristine; D013866:Thioguanine; D002066:Busulfan; D011241:Prednisone
Resultados citogenéticos y terapéuticos de un protocolo de esplenectomía y poliquimioterapia intensiva en la leucemia mieloide crónica Ph'-positive.